Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lexicon Pharmaceutcl (NQ: LXRX )

2.200 -0.090 (-3.93%)
Streaming Delayed Price Updated: 3:44 PM EDT, Mar 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 283,839
Open 2.300
Bid (Size) 2.200 (12)
Ask (Size) 2.210 (26)
Prev. Close 2.290
Today's Range 2.200 - 2.300
52wk Range 1.310 - 3.480
Shares Outstanding 144,474,452
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Lexicon Pharmaceuticals's Return On Capital Employed Insights
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
 
Via Benzinga

Performance

YTD
+10.55%
+10.55%
1 Month
-0.90%
-0.90%
3 Month
+14.29%
+14.29%
6 Month
-13.04%
-13.04%
1 Year
+1.38%
+1.38%

More News

Read More
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday
Via Benzinga
Earnings Preview For Lexicon Pharmaceuticals
Via Benzinga
Lexicon Pharmaceuticals's Return On Capital Employed Overview
Via Benzinga
Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Lexicon Pharma's Pain Candidate Fails In Postherpetic Neuralgia Study
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Micron, Lexicon Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
Why ORIC Pharmaceuticals Shares Are Trading Higher By Around 46%; Here Are 27 Stocks Moving Premarket
Via Benzinga
Lexicon's Experimental Drug Shows Significant, Consistent Benefits In Diabetic Neuropathy Study
Via Benzinga
Earnings Outlook For Lexicon Pharmaceuticals
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
Via Benzinga
Recap: Lexicon Pharmaceuticals Q2 Earnings
Via Benzinga
More Than $40 Million Bet On This Penny Stock? Check Out These 3 Penny Stocks Insiders Are Buying
Via Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
Via Benzinga
This Financial Services Is Trading Higher By Over 217%; Here Are 38 Stocks Moving Premarket
Via Benzinga
Lexicon Pharmaceuticals Earnings Preview
Via Benzinga
Earnings Scheduled For August 2, 2022
Via Benzinga
Why Amazon Is Trading Higher By 12%: Here Are 23 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate
Via Benzinga
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
Via Benzinga
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.